Skip to main navigation Skip to search Skip to main content

XENFORM: A Prospective, Non-Randomized, Parallel Cohort, Multi-Center Study of Xenform vs. Native Tissue for the Treatment of Women with Anterior/Apical Pelvic Organ Prolapse

Project: Research

Project Details

StatusFinished
Effective start/end date06/16/1406/15/20

Funding

  • Boston Scientific Corporation: $67,702.00